"Neoplasms, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
| Descriptor ID |
D009374
|
| MeSH Number(s) |
C04.619 E05.598.500.496
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms, Experimental".
- Neoplasms, Experimental
- Carcinoma 256, Walker
- Carcinoma, Brown-Pearce
- Carcinoma, Ehrlich Tumor
- Carcinoma, Krebs 2
- Carcinoma, Lewis Lung
- Leukemia, Experimental
- Liver Neoplasms, Experimental
- Mammary Neoplasms, Experimental
- Melanoma, Experimental
- Sarcoma, Experimental
This graph shows the total number of publications written about "Neoplasms, Experimental" by people in this website by year, and whether "Neoplasms, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 2 | 0 | 2 |
| 1996 | 3 | 1 | 4 |
| 1997 | 3 | 2 | 5 |
| 1998 | 0 | 1 | 1 |
| 1999 | 4 | 1 | 5 |
| 2000 | 2 | 0 | 2 |
| 2001 | 2 | 1 | 3 |
| 2002 | 5 | 4 | 9 |
| 2003 | 3 | 2 | 5 |
| 2004 | 4 | 2 | 6 |
| 2005 | 5 | 2 | 7 |
| 2006 | 3 | 3 | 6 |
| 2007 | 2 | 3 | 5 |
| 2009 | 2 | 3 | 5 |
| 2010 | 3 | 0 | 3 |
| 2011 | 2 | 3 | 5 |
| 2012 | 6 | 2 | 8 |
| 2013 | 1 | 2 | 3 |
| 2014 | 4 | 3 | 7 |
| 2015 | 3 | 1 | 4 |
| 2016 | 5 | 2 | 7 |
| 2017 | 4 | 4 | 8 |
| 2018 | 3 | 3 | 6 |
| 2019 | 3 | 0 | 3 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms, Experimental" by people in Profiles.
-
Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers. J Clin Invest. 2022 02 15; 132(4).
-
Criteria to make animal studies more relevant to treating human cancer. Curr Opin Immunol. 2022 02; 74:25-31.
-
Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion. Cancer Res. 2020 11 01; 80(21):4707-4719.
-
A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target. J Clin Invest. 2020 03 02; 130(3):1405-1416.
-
Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors. Cancer Immunol Res. 2020 02; 8(2):192-202.
-
Tumor-reprogrammed resident T cells resist radiation to control tumors. Nat Commun. 2019 09 02; 10(1):3959.
-
CD73: an emerging checkpoint for cancer immunotherapy. Immunotherapy. 2019 08; 11(11):983-997.
-
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum. J Exp Med. 2019 01 07; 216(1):176-194.
-
Non-canonical NF-?B Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy. Immunity. 2018 09 18; 49(3):490-503.e4.
-
Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice. Cancer Immunol Res. 2018 11; 6(11):1301-1313.